We gave priority in this study to investigate the chemotherapy effect of albumin-bound paclitaxel combined with pirarubicin and cyclophosphamide on breast cancer and the effects of PCR, ORR and CBR, aiming to further optimize neoadjuvant chemotherapy regimen for breast cancer patients and improve their prognosis. Here, ALB is linked to breast cancer.